SPOTLIGHT: Top 17 Paychecks in Big Pharma


Few statistics are as hotly debated as CEO pay reports. Investors, analysts, and the just plain curious all want to know how much the head honcho makes--and how one company's chief stacks up against another's. We've already ranked the top five Big Biotech CEO salaries, so here for your rubbernecking pleasure are the 17 best-paid CEOs in Big Pharma. While the names themselves probably won't be a surprise, the pecking order might. List

Suggested Articles

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.

The trial linked RG6346 to reductions in hepatitis B surface antigen that suggest the RNAi therapy can hold its own against drugs from J&J and Vir.